BioWorld

March 24, 2004

View Archived Issues

Structural GenomiX Signs First FAST Platform Partner: Serono

In a deal worth up to $68 million, Structural GenomiX agreed to use its FAST drug discovery technology with Serono SA to develop small-molecule therapeutics. (BioWorld Today) Read More

Shire Could Pay AnorMed Up To $31M For Fosrenol Global Patents

Read More

After Chemo-Induced Menopause, Fertility In Breast Cancer Patient Restored By Cryopreservation

Read More

Bioenvision Stock Placement Gets $12.8M For Clofarabine

Read More

Other News To Note

Read More

Appointments And Advancements

Read More